| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $211.0M | -0.0% |
| Cost of Revenue | $77.1M | +5.5% |
| Gross Profit | $133.9M | -3.0% |
| R&D Expense | $33.5M | +5.7% |
| SG&A Expense | $32.5M | +11.2% |
| Operating Income | -$8.0M | -206.0% |
| Interest Expense | $205K | — |
| Pre-tax Income | -$9.1M | -246.3% |
| Income Tax | -$52K | -106.5% |
| Net Income | -$9.0M | -267.0% |
| EPS (Basic) | -$0.22 | -269.2% |
| EPS (Diluted) | -$0.22 | -269.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.9M | -30.3% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $26.0M | -12.9% |
| Current Assets | $77.3M | -17.9% |
| Total Assets | $227.8M | +5.2% |
| Current Liabilities | $104.0M | +7.6% |
| Total Liabilities | $125.5M | +4.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.4M | +29.9% |
| Capital Expenditures | $10.7M | +386.5% |
| Investing Cash Flow | -$37.8M | -248.3% |
| Financing Cash Flow | -$83K | -111.8% |
| Free Cash Flow | $14.7M | -15.3% |
| Stockholders' Equity |
| $102.3M |
| +6.3% |